Service Agreement for one GeneXpert GX-XVI R2 instrument, one GeneXpert GX16-16 instrument, and one GeneXpert GX4-4 10 color instrument.

The Center for Disease Control and Prevention (CDC), Global Health Center (GHC) intends to issue a modification to existing purchase order 75D30123M17407 on a sole source basis to Cepheid, 904 East Caribbean Drive, Sunnyvale, CA 94089, to add additional lab instruments to the existing maintenance service agreement.

The authority for this sole source acquisition is in accordance with FAR Part 12.102(a).

Maintenance service contractor Cepheid manufactures the GeneXpert instruments and is the sole source provider for maintenance service agreements to maintain the functionality of these instruments. As the original equipment manufacturer, only Cepheid has access to the proprietary technical specifications, parts, and calibration protocols required to properly service the instruments, and using a non-authorized provider would risk compromising instrument performance and the reliability of diagnostic test results. Therefore, Cepheid is the only responsible source capable of providing these maintenance services.

As a result of this synopsis, no competitive solicitation will be posted on sam.gov. We will issue only one solicitation to the identified entity. However, responsible sources that believe they can meet these requirements are encouraged to identify themselves and give written notice by providing a capability statement to the Contracting Officer by the closing date of this posting. The Contracting Officer will not respond to verbal request. All requests must be in writing.

A determination by the Government not to compete this proposed action will be based on responses to this notice and are solely within the discretion of the Contracting Officer. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement.

Inquiries shall be sent to Liubov Kriel by email at vyh1@cdc.gov and reference solicitation #2026-Q-95500 on the subject line.